What are some psychosocial factors that may impact a patient's compliance with INH therapy?

The choice highlighting stigma, lack of support, and mental health issues is particularly relevant to understanding patient compliance with isoniazid (INH) therapy.

Stigma related to tuberculosis (TB) can deter patients from seeking treatment or following through with their prescribed therapy due to fear of being judged or ostracized by their community. This social stigma can create a barrier to open discussion about the illness and reduce the likelihood of patients adhering to their treatment regimen.

The lack of social support plays a critical role in a patient's ability to comply with a treatment plan. Support from family, friends, or support groups can encourage patients to stay engaged with their treatment. When patients feel isolated or unsupported, they may be less motivated to continue therapy, increasing the risk of treatment discontinuation.

Mental health issues also significantly influence a patient's willingness and ability to adhere to treatment. Conditions such as depression or anxiety can lead to a lack of focus on health, overwhelming feelings that make it hard to manage daily tasks, including taking medications as prescribed. Addressing these psychosocial factors is important for improving compliance with INH therapy and ensuring effective treatment outcomes.

Overall, addressing stigma, providing social support, and attending to mental health can directly impact a patient's adherence and overall success with